An estimated 500 000 individuals in the US, mostly steroid-dependent asthmatics, suffer severe adverse reactions to sulfites in foods, beverages, and pharmaceuticalproducts. In an attempt to understand the pathogenesis of sulfite hypersensitivity, we have developed an assay for the determination of totalserum sulfite by utilizing: (a) reductive release of serum protein-bound sulfite; (b) derivatization of freesulfite with monobromobimane; (c) separation of sulfite-bimanefrom thiol-bimanes by reversed-phase HPLC; and (c quantitation of sulfite-bimaneby fluorescencedetection. The detection limitof this assay was 0.44 moVL serum sulfite. The intra-and interassayCVs for totalserum sulfite at 5.4 moVL were 8.1% and 22.0%, respectively. The standard addition method was used to determine total serum sulfite in normal subjects. More than 70 samples were prepared in 2-3 h, followed by automated overnight analysis. The mean concentrations (± SD) of total serum sulfite in female (n = 41) and male (n = 35) donors were 4.63 ± 2.33 and 5.16 ± 2.68 moVL, respectively (not statistically significant: P = 0.368). The combined mean concentration of total sulfite in both sexes was 4.87 ± 2.49 mol/L.
manes by reversed-phase HPLC; and (c quantitation of sulfite-bimaneby fluorescencedetection. The detection limitof this assay was 0.44 moVL serum sulfite. The intra-and interassayCVs for totalserum sulfite at 5.4 moVL were 8.1% and 22.0%, respectively. The standard addition method was used to determine total serum sulfite in normal subjects. More than 70 samples were prepared in 2-3 h, followed by automated overnight analysis. The mean concentrations (± SD) of total serum sulfite in female (n = 41) and male (n = 35) donors were 4.63 ± 2.33 and 5.16 ± 2.68 moVL, respectively (not statistically significant: P = 0.368). The combined mean concentration of total sulfite in both sexes was 4.87 ± 2.49 mol/L.
There was no correlation between total serum sulfite and total serum cysteine, cysteinylglycine, homocysteine, subject age, serum cobalamin, or serum folic acid. The reference range (mean ± 2 SD) for total serum sulfite in normal subjects is 0-9.85 moVL.
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Sulfur dioxide and other sulfur compounds naturally cycle through the biosphere, but as a result of increased industrial activities over the past several decades, unnatural entry of sulfur into the biosphere will soon equal or even surpass natural sources (1) . The tragic consequences of the London "killer fogs" earlier this century were due in part to the presence of oxidized forms of sulfur produced during the burning of coal and other fossil fuels (2). Sulfur dioxide and sulfite salts, known generically as "sulfiting agents," have been widely used by the food, beverage, and pharmaceutical industries as antioxidants, antibrowning agents, and antimicrobials (3, 4) . Until recently, sulfiting agents were given generally-recognized-as-safe status, which allowed their use in foods and beverages without disclosure. It was reasoned that ingested suffite, a normal sulfur metabolite of cysteine catabolism (the average adult produces 1 g of sulfite per day), would be rapidly oxidized to sulfate by the mitochondrial enzyme sulfite oxidase and excreted in the urine without untoward effects. Indeed, this is what happens in normal healthy subjects. However, some individuals are hypersensitive and suffer life-threatening reactions after ingesting sulfites.
Reports of several fatalities associated with exposure to food or pharmaceutical sulfites during the past 20 years have forced the Food and Drug Administration to severely restrict the use of these agents (5, 6).
Although the true incidence is unknown, an estimated 3-5% of the 10 million asthmatics in the US are hypersensitive to sulfiting agents (7, 8) (14) . A reference range in healthy individuals is also reported.
Materials and Methods

Materials.
The following reagents were purchased from commercial sources: sodium borohydride Sulfite loading test. A healthy male and a healthy female volunteer were given sodium metabisulfite (20 mg/kg body weight) dissolved in 6 oz. of vegetable juice (V-8) by mouth. Blood was drawn immediately before and after ingestion of the suffite cocktail at intervals of 15 mum for the first hour, 30 mm for the second hour, and 60 mm for the third to sixth hour. Serum samples were processed for total sulfite as described above.
Interference study. Hemolyzed blood samples were analyzed to determine the effect of hemoglobin on the sulfite assay. Fig. 1A . The uncorrected excitation and emission fluorescence spectra of sulfite-bimame (Fig.  1B) exhibited maxima at 392 and 479 mm, respectively. The absorbance, fluorescence, and HPLC properties of cysteine-S-bimane, cysteinyl(-S-bimane)glycine, homocysteine-S-bimane, and glutathione-S-bimane have been described previously (18, 20, 21) . Sulfiteand thiol-bimane calibrators were used to identify the mBrB derivatives of suffite and other low-molecularmass thiols in human serum as shown in Fig. 2(A and  B) . As shown in Fig. 2B , the retention times for cystemne-S-bimane, sulfitebimame, homocystemme-Sbimane, and glutathione-S-bimane calibrators were 6.85, 7.76, 9.67, and 10.78 mm, respectively
[the cysteimyl(-S-bimane)glycine calibrator was not present in this run]. In human serum the retention times for the bimame adducts of cysteine, cysteinylglycine, sulfite, homocysteine, and glutathione were 6.70, 7.39, 7.82, 9.67, and 10.70 mm, respectively ( Fig. 2A) . Reaction blanks in which water replaced serum had no identifiable peaks in the sulfite-bimane area (Fig. 2C) .
Sulfite, pmoi/L
Optimization of assay conditions. The concentration of each reagent used in the assay was optimzed to achieve the greatest possible sensitivity. Fig. 3 . The response to added sulfite was linear over the concentration range shown. Intraassay CVs were 8.1%, 8.6%, and 7.8% for mean sulfite concentrations of 5.71, 13.6, and 55.0 moVL, respectively (Table 1) . Biweekly analyses of the serum quality controls for a 3-month period gave interassay CVs of 22.0%, 12.6%, and 14.2% for Fig. 3 . Calibration curve for total serum sulfite.
Standardized amounts of sodium sulfite were added to aliquots of normal human serum and assayed for total serum sulfite as described in Materials and Methods. 4) as a blank. Under these conditions, the detection limit for sodium sulfite was 0.44 mo1IL.
Interference.
The effect of hemolysis on the determination of total serum sulfite was investigated.
Sulfite concentrations did not appear to be affected by hemolysis (Table 2 ). Mean total serum sulfite concentrations in samples with increasing concentrations of hemoglobin did not consistently differ from the mean total serum sulfite concentration in a monhemolyzed sample. Thus, sulfite can be determined in serum samples that have been obtained from hemolyzed blood.
Serum Reference Range and Oral Sulfite Loading in
Healthy Donors
Total serum sulfite in healthy donors. Total serum sulfite was determined in sera from 75 apparently healthy donors who had fasted. The mean concentrations (±SD) of total serum sulfite in female (n = 41) and male (n = 34) donors were 4.63 ± 2.33 and 5.16 ± 2.68 moI/L, respectively. There was no statistically significant difference in total serum sulfite concentrations between men and women (P = 0.368). Total serum sulfite was approximately normally distributed within both gender groups, as revealed by the ShapiroWilk's test for normality.
The combined mean comcem- range (mean ± 2 SD) for total serum sulfite in this population was 0-9.85 moIJL. As shown in Fig. 4 , total serum sulfite concentrations appeared to be normally distributed, but were slightly skewed toward higher values. Total serum cysteine, cysteinylglycine, and homocysteine have been previously reported for these subjects (18) . No correlations were found between total serum sulfite and total serum cysteime In addition, no correlations were found between total serum sulfite and the subjects' ages (Spearman correlation r = 0.1059; P = 0.387), serum cobalamim (r = 0.0414; P = 0.737), or serum folic acid (r = -0.0997; P = 0.419). Oral sulfite-loading studies. Sodium metabisulfite (dose = 20 mg/kg body weight) was dissolved in vegetable juice and given orally to two individuals.
There was a rapid rise in total serum sulfite that reached a maximum concentration (112 and 38 moI/L in subjects 1 and 2, respectively) in -30 mm (see Fig. 5 ). This was followed by a rapid fall in suffite concentration in subject 1 and a moderately rapid fall in subject 2. Total serum sulfite concentrations in both individuals approached basal concentrations in -3 h. However, sulfite concentrations were still slightly increased at the end of 6 h in both subjects.
Discussion
A rapid and sensitive assay for total serum sulfite has been developed, based on: (a) release of proteinbound sulfite by sodium borohydride reduction to liberate sulfite from protein-S-sulfonates;
(b) derivatization of free sulfite with mBrB to form suffite-bimane; (c) separation of sulfite-bimane from low-molecularmass serum thiol-bimanes by reversed-phase HPLC;
and (d) detection and quantitation of sulfite-bimane by fluorometry.
We have previously described assays for low-molecular-mass thiols in serum and plasma involving mBrB (18, 19) . The present assay for total serum Because sulfite reacts with protein disulfide bonds to form protein-S-sulfonates, it is necessary to include a reduction step in the assay to measure "total" serum sulfite. Borohydride has been used previously as a reducing agent to liberate homocystemne from protein in assays for total serum homocysteine and other thiols (19, (24) (25) (26) .
The use of mBrB as a thiol-specffic denvatization reagent and its use in HPLC with fluorescent detection is well established (21, 27) . A sulfitebimane adduct, prepared as a calibrator, has been previously reported by Fahey and Newton (21) . Total sulfite refers to all forms of sulfite in serum or plasma, including protein-bound sulfonates and low-molecularmass S-sulfonates such as cysteine-S-sulfonate and free sulfite. Evidence for the in vivo formation of plasma proteim-S-sulfonates has been provided by Gregory and Gunnison (28) , who demonstrated that sulfite, when infused intravenously into rabbits, could later be isolated as albumin-S-sulfonate and fibronectin-S-sulfonate.
The endogemous forms of sulfite in normal human serum remain to be identified. The existence of free sulfite exits in normal human serum has not been previously demonstrated. However, oral sulfite loading studies are in progress to address these questions.
Because sulfite reacts with disulfide bonds of proteins and small molecules such as cysteine, the half-life of free sulfite in normal individuals is probably short. Mansoor In experimental animals the concentrations of protein-bound sulfite in nonfasting rats (n = 11) and rhesus monkeys (n = 5) were 8.0 ± 4.0 and 3.0 mol/L, respectively (32). Acosta et al. (37) , using the method of Grant (36) to determine plasma sulfite concentration, reported a very high concentration of suffite in a sulfite-sensitive individual.
In their report, the sulfite concentration in plasma before sodium metabisulfite loading was -90 mg/L (1.13 mmoL'L). After metabisulfite loading with a capsule containing 200 mg of sodium metabisuffite, plasma sulfite peaked at -2.13 mmol/L 6 mm after ingestion and fell to baseline within 60 mm. Although suffite metabolism may be impaired in patients with sulfite hypersensitivity (38) , the basal and postload plasma sulfite values in this single patient are 100 to 500 times higher than the serum values reported in this study for normal individuals. Togawa et al. (13) reported that the mean concentration of total serum sulfite in five normal subjects was 0.47 ± 0.25 moIJL by an assay based on dithiothreitol reduction of serum, flow gas dialysis to isolate sulfur dioxide, conversion back to sulfite in sodium hydroxide, mBrB derivatization, and HPLC analysis with fluorescence detection. The method gave high sensitivity and good resolution with tandem C18 reversed-phase and ion-exchange columns. The mean serum sulfite concentration reported by Togawa et al. is -10% of the mean serum sulfite concentration found in this study. Although ethnic and dietary backgrounds of the study subjects could explain at least some of the difference, the disparity is more likely related to methodologies.
For example, dithiothreitol was used as a reducing agent in the Togawa study and sodium borohydride in this study. In the present study the mean concentrations of total serum sulfite in female and male donors were not statistically significant.
The combined mean concentration of total serum sulfite was 4.87 ± 2.49 molfL (median = 4.44 molJ'L). The reference range (mean ± 2 SD) for total serum sulfite in healthy subjects is thus 0-9.85 moWL. Total serum sulfite was also evaluated in 65 patients with low serum B12 and (or) folic acid (data not shown). Although the mean concentration of total serum sulfite in this group of patients was slightly lower (4.09 ± 2.59 .tmoIIL) than in healthy subjects, the difference was not statistically significant. When the data from the two groups were combined (n = 141), the distribution of total serum sulfite was also normal. To our knowledge this is the first reported reference range for total serum sulfite in humans.
To determine whether sulfite could be detected in the circulation after oral ingestion, two individuals consumed a vegetable juice cocktail containing dissolved sodium metabisulfite (20 mg/kg body weight). Blood samples drawn immediately before consumption and them periodically for up to 6 h postconsumptiom were processed for total serum sulfite. Total serum concentrations increased rapidly after ingestion, reaching a peak within 30 mm. They then declined to near baseline concentrations within 3 h but never quite reached basal values within the 6-h time course. Additional oral sulfite-loading studies will be needed to establish at what time basal concentrations are achieved. This will require extended time-course studies. There was considerable variability in the kinetics of serum sulfite appearance and disappearance in the two individuals studied, and further studies will be needed to establish the extent of variability among individuals. Oral provocation tests used in the diagnosis of sulfite hypersensitivity generally start at low doses (e.g., 5 mg total body dose) and then increase until a triggering dose is established in sensitive individuals (9, 10) . If sulfite metabolism is impaired in sensitive individuals, possibly the current assay could be used to follow the kinetics of serum sulfite after oral loading in these patients with relatively low total body doses.
In conclusion, this sensitive assay for total serum sulfite, developed by using the standard addition method and HPLC with fluorescence detection, is sufficiently sensitive and specific to detect sulfite in normal subjects, for which the reference range is 0-9.85 p.mol/L. Hemolysis does not interfere with the assay. 
